INDSWFTLAB.NS Ind-Swift Laboratories Limited

P/E 46.58471
Forward P/E --
Price/Sales 3.057451
Beta 0.579
Div Yield --
Market Cap --

Company Analysis

Latest News

🟢 Ind-Swift Laboratories is trading 5% up today amid broad risk-on recovery

Ind-Swift Laboratories is trading at INR 399.00 (+5.17%) after a broad risk-on recovery in equities supported by falling oil prices and declining Treasury...

🟢 Ind-Swift Laboratories is trading 5.77% up today

Ind-Swift Laboratories is trading at INR 384.90 (+5.77%), with no clear company-specific catalyst identified for September 17, 2026. • Recent coverage...

🔴 Ind-Swift Laboratories is trading 12.87% down today with no clear catalyst identified

Ind-Swift Laboratories is trading 12.87% down now at ₹330.00 after no clear company-specific catalyst was identified for the September 16, 2026 decline. -...

🔴 Ind-Swift Laboratories is trading 5.9% down; no clear catalyst identified

Ind-Swift Laboratories is trading 5.9% down at ₹356.40, with no clear company-specific catalyst identified. - September 16, 2026 coverage does not identify a...

Ind-Swift's Warrant Price Set at Half Its Market Value — Is the Discount a Dilution Risk or a Confidence Signal?

Ind-Swift's Warrant Price Set at Half Its Market Value — Is the Discount a Dilution Risk or a Confidence Signal?

Shares of Ind-Swift Laboratories surged as much as 12.4% to INR 400.25 on September 7, after the company locked in a preferential warrant issue price of INR...

🟢 Ind-Swift Laboratories is trading 8.56% up today after fixing warrant issue price at INR 196

Ind-Swift Laboratories is trading 8.56% up at INR 400.25 after fixing its preferential allotment warrant issue price at INR 196 each. - The announcement...

🔴 Ind-Swift Laboratories is trading 5.82% down

Ind-Swift Laboratories is trading 5.82% down at INR 351.00, after falling from its September 3 close of INR 372.70, with no reliable company-specific catalyst...

🟢 Ind-Swift Laboratories is trading 5.7% up

Ind-Swift Laboratories is trading 5.7% up at ₹385.60 after no clearly documented company-specific catalyst was identified for September 1, 2026. - Recent...

🟢 Ind-Swift Laboratories is trading 11.81% up today — catalyst remains unclear

Ind-Swift Laboratories is trading at INR 362.68, up 11.81%, with no clear company-specific announcement directly explaining the August 26, 2026 move. - Recent...

🟢 Ind-Swift Laboratories is trading 5.8% up today

Ind-Swift Laboratories is trading at INR 343.28, up 5.83%, with no clear company-specific announcement explaining the August 26, 2026 move. - Q1 FY27 PAT rose...

🔴 Ind-Swift Laboratories is trading 5.38% down today after an exceptional rally

Ind-Swift Laboratories is trading 5.38% down at INR 328.22, following an exceptional rally from INR 237.24 on August 10 to INR 313.02 on August 17. No clear...

Ind-Swift Labs Triples Its Operating Profit and Stock Surges 45% in a Week — But Can a Small Pharma Sustain This Momentum

Ind-Swift Labs Triples Its Operating Profit and Stock Surges 45% in a Week — But Can a Small Pharma Sustain This Momentum

Shares of Ind-Swift Laboratories rocketed as much as 13.3% on August 18, landing at INR 344.58, capping a stunning 45% rally from the INR 237.24 close just...

🟢 Ind-Swift Laboratories is trading 10.08% up today after strong Q1 FY27 results

Ind-Swift Laboratories is trading 10.08% up at INR 344.58, as investors continued responding to strong Q1 FY27 results and the August 17, 2026 earnings-call...

🟢 Ind-Swift Laboratories is trading 5.61% up today after strong Q1 FY27 results

Ind-Swift Laboratories is trading 5.61% up now at INR 330.59, as investors continue responding to strong Q1 FY27 results and the August 17 earnings-call...

🟢 Ind-Swift Laboratories is trading 11.75% up today after 201.05% profit jump

Ind-Swift Laboratories is trading at ₹318.14, up 11.75%, after standalone net profit jumped 201.05% year-on-year to ₹24.44 crore in the June quarter. - EBITDA...

Ind-Swift Labs Surges 20% on Promoter Warrant Deal — Is This Expansion Bet Worth the Dilution Risk?

Ind-Swift Labs Surges 20% on Promoter Warrant Deal — Is This Expansion Bet Worth the Dilution Risk?

Shares of Ind-Swift Laboratories vaulted 20% to ₹274.10 on August 11, extending a sharp rally after shareholders greenlit a ₹137.20 crore warrant issue to...

🟢 Ind-Swift Laboratories surges 15.54% on strong Q1 earnings and approval of ₹137.20 crore warrants

Ind-Swift Laboratories is trading at INR 274.10 (+15.54%) today, driven by two key company-specific catalysts. The company reported significantly improved...

🟢 Ind-Swift Laboratories is trading 5% up today after shareholder approval of ₹137.20 crore warrants

Ind-Swift Laboratories is trading at INR 240.00, up +5.07%, after shareholder approval of ₹137.20 crore of fully convertible warrants to promoter entities on...

🔴 Ind-Swift Laboratories is trading 5% down today amid potential profit-taking after recent gains

Ind-Swift Laboratories is trading at INR 224.49, down 5% today, as the stock gives back a portion of its recent gains in a move likely driven by...

🟢 Ind-Swift Laboratories is trading 5% up today following a Q4 results-driven re-rating and sector tailwinds

Ind-Swift Laboratories is trading 5% up at $238.99 following a strong re-rating move triggered by its recent quarterly performance. • The primary catalyst for...